BERLIN -- Adding a test that predicts cancer signal origin to single standard of care (SoC) screening substantially increased ...

AccuGenomics, Inc., a US-based leader in next-generation sequencing (NGS) quality standards, and 1Cell.Ai, a US-based precision oncology company specializing in single-cell and liquid biopsy ...

MVZ HPH Institute for Pathology and Hematopathology GmbH, today announced the availability of HPH MRD, a new tumor-informed ...

“With newer advances, cancer care has definitely reached a point where it is no longer a threat to life, but a journey that ...

Molecular testing helps distinguish kidney cancer subtypes, ensuring patients get accurate diagnoses and treatment plans, avoiding unnecessary surgery. Molecular testing can help doctors distinguish ...

More Than Half of Cancers Detected by Galleri Were Early Stage Approximately Three-Quarters of Galleri-Detected Cancers Do Not Have Recommended Screenings ...

Key market opportunities in liquid biopsy for early cancer detection include increasing demand for non-invasive diagnosis, driven by rising cancer cases and precision oncology trends. Advancements in ...

Nearly half of patients with metastatic castration-resistant prostate cancer harboring BRCA1/2 alterations do not receive ...

A new era in Indian healthcare has begun with the inception of EarlySure Diagnostics Limited, a visionary venture poised to ...

In the shadow of tall monuments, bustling bazaars and a rich culture, breast cancer casts a long, dark shadow over Pakistan.

The Association for Molecular Pathology released best practice recommendations for improving how complex molecular profiling information is presented to oncologists and other healthcare providers.